I came across the results of a survey from the Journal of Urology, that was sent out to 1,422 prostate cancer specialists in the United States. They were queried about
self-reported clinical implementation of quality of life instruments, prostate cancer nomograms and life expectancy prediction tools. Here's the link:
I thought the "Conclusion" was most telling:
"Although prostate cancer nomograms have been implemented into clinical practice to some degree, the use of quality of life and life expectancy tools has been more limited. Increased attention to implementing validated instruments into clinical practice may facilitate shared decision making for patients with prostate cancer."
From my perch it gets back into having to be your own health care advocate - although unfortunately that won't help the denizens out there that don't know enough to be able to do so, and instead rely entirely upon their medical practitioner.
55 yrs old, excellent health - DX'd with PCa July '12
9 of 12 Gleason: 3+3 <5%, 3+3 <5%, 3+3 <5%, 3+3 <5%, 3+4 5-10%, 3+4 <5%, 3+4 5-10%, 3+4 30-40%, 3+4 15-20% (All neg PNI)
Negative DRE’s / NO / MO / T1C / Gland size 40gm / Vol. 22gm
Volume Study 8/14/12
Casodex 50mg daily 5 wks prior 2 wks post BT
LDR BT 9/21/12 – no issues
3 mo PSA 12/20 0.48!
6 mo PSA 3/14 0.21!